Cargando…
Erenumab safety and efficacy in migraine: A systematic review and meta-analysis of randomized clinical trials
BACKGROUND: Erenumab is a new medicine recently approved in the United States of America for the preventive treatment of migraine among adults. We aimed to conduct a meta-analysis and evaluation of the efficacy and safety of erenumab among patients with migraine. METHODS: The electronic databases th...
Autores principales: | Zhu, Changyu, Guan, Jianmei, Xiao, Hua, Luo, Weinan, Tong, Rongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946432/ https://www.ncbi.nlm.nih.gov/pubmed/31876735 http://dx.doi.org/10.1097/MD.0000000000018483 |
Ejemplares similares
-
Assessing the efficacy and safety of Craniosacral therapy for migraine: A single center randomized controlled trial
por: Jiang, Guangya, et al.
Publicado: (2023) -
The efficacy of dexketoprofen for migraine attack: A meta-analysis of randomized controlled studies
por: Yang, Baohua, et al.
Publicado: (2019) -
Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials
por: Chang, Kuo-Hsuan, et al.
Publicado: (2015) -
Unveiling the comparative efficacy and tolerability of comprehensive treatments for migraine: A protocol of systematic review and Bayesian network meta-analysis
por: Jin, Boru, et al.
Publicado: (2021) -
Efficacy and safety of siponimod for multiple sclerosis: Protocol for a systematic review and meta-analysis
por: Song, Yumeng, et al.
Publicado: (2019)